These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 39031554)
1. Advances in nano-preparations for improving tetrandrine solubility and bioavailability. Ling J; Wu J; Cao Y; Zhang T; Cao X; Ge X; Liu Y; Wang M; Ren B; Lu J Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400274. PubMed ID: 39031554 [TBL] [Abstract][Full Text] [Related]
2. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. Luan F; He X; Zeng N J Pharm Pharmacol; 2020 Nov; 72(11):1491-1512. PubMed ID: 32696989 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145 [TBL] [Abstract][Full Text] [Related]
4. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. Jia L; Li Z; Shen J; Zheng D; Tian X; Guo H; Chang P Int J Pharm; 2015 Jul; 489(1-2):318-30. PubMed ID: 25956050 [TBL] [Abstract][Full Text] [Related]
5. An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. Xu H; Hou Z; Zhang H; Kong H; Li X; Wang H; Xie W Int J Nanomedicine; 2014; 9():231-42. PubMed ID: 24403829 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Pro-Apoptotic Effect of Tetrandrine Loaded Nanoparticles Against Osteosarcoma Cells. Tian Y; Yin H; Xu H Curr Drug Deliv; 2016; 13(6):946-52. PubMed ID: 26935259 [TBL] [Abstract][Full Text] [Related]
7. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation. Zhang H; Tian Y; Zhu Z; Xu H; Li X; Zheng D; Sun W Sci Rep; 2016 May; 6():26546. PubMed ID: 27226240 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line. Xu H; Li X; Kong H; Zeng X; Jin Y; Qi Y; Wang H; Xie W J Biomed Nanotechnol; 2016 Aug; 12(8):1699-707. PubMed ID: 29342348 [TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. Li S; Ji Z; Zou M; Nie X; Shi Y; Cheng G AAPS PharmSciTech; 2011 Sep; 12(3):1011-8. PubMed ID: 21811889 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the cancer-associated TASK 3 channels by magnetically induced thermal release of Tetrandrine from a polymeric drug carrier. Shi C; Thum C; Zhang Q; Tu W; Pelaz B; Parak WJ; Zhang Y; Schneider M J Control Release; 2016 Sep; 237():50-60. PubMed ID: 27374629 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, purification, and anticancer effect of magnetic Fe Wang K; Hu H; Zhang Q; Zhang Y; Shi C J Microencapsul; 2019 Jun; 36(4):356-370. PubMed ID: 31190597 [TBL] [Abstract][Full Text] [Related]
13. Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells--a possible Trojan strategy against cancer. Li X; Zhen D; Lu X; Xu H; Shao Y; Xue Q; Hu Y; Liu B; Sun W Eur J Pharm Biopharm; 2010 Aug; 75(3):334-40. PubMed ID: 20438840 [TBL] [Abstract][Full Text] [Related]
14. Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis. Li X; Yu N; Li J; Bai J; Ding D; Tang Q; Xu H ACS Appl Mater Interfaces; 2020 Mar; 12(9):10096-10106. PubMed ID: 32027119 [TBL] [Abstract][Full Text] [Related]
15. Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study. Liu C; Lv L; Guo W; Mo L; Huang Y; Li G; Huang X Biomed Res Int; 2018; 2018():6763057. PubMed ID: 30363745 [TBL] [Abstract][Full Text] [Related]
16. Surfactant-free poly(lactide-co-glycolide) nanoparticles for improving in vitro anticancer efficacy of tetrandrine. Shi C; Zeng F; Fu D J Microencapsul; 2016 May; 33(3):249-56. PubMed ID: 26961245 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy". Li X; Lu X; Xu H; Zhu Z; Yin H; Qian X; Li R; Jiang X; Liu B Mol Pharm; 2012 Feb; 9(2):222-9. PubMed ID: 22171565 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Li J; Guo X; Liu Z; Okeke CI; Li N; Zhao H; Aggrey MO; Pan W; Wu T Drug Dev Ind Pharm; 2014 Jul; 40(7):980-7. PubMed ID: 23662696 [TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Ng LT; Chiang LC; Lin YT; Lin CC Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745 [TBL] [Abstract][Full Text] [Related]
20. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Liu T; Liu X; Li W Oncotarget; 2016 Jun; 7(26):40800-40815. PubMed ID: 27027348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]